Hans-Georg Kress Selected Research

Pain (Aches)

4/2021	[Interdisciplinary position paper: the value of radiofrequency denervation in the treatment of chronic pain].
1/2020	TRPV1 antagonist BCTC inhibits pH 6.0-induced pain in human skin.
1/2019	A Human TRPA1-Specific Pain Model.
10/2018	European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management.
1/2016	Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component: A Randomized, Double-blind, Placebo-controlled Crossover Trial.
1/2015	A holistic approach to chronic pain management that involves all stakeholders: change is needed.
9/2014	Pain in the cancer patient: different pain characteristics CHANGE pharmacological treatment requirements.
6/2014	Managing chronic pain in elderly patients requires a CHANGE of approach.
1/2011	Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
7/2008	Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans-Georg Kress Research Topics

Disease

11	Pain (Aches) 04/2021 - 09/2003
4	Chronic Pain 04/2021 - 01/2011
3	Neuralgia (Stump Neuralgia) 09/2014 - 07/2008
2	Low Back Pain (Lumbago) 01/2016 - 01/2011
2	Neoplasms (Cancer) 09/2014 - 07/2008
2	Cancer Pain 09/2014 - 07/2008
1	Acidosis 01/2020
1	Migraine Disorders (Migraine) 09/2016
1	Breakthrough Pain 09/2014
1	Acute Pain 01/2011
1	Nociceptive Pain 07/2008
1	Autoimmune Diseases (Autoimmune Disease) 07/2008
1	Communicable Diseases (Infectious Diseases) 07/2008
1	Hypoventilation 07/2008
1	Respiratory Insufficiency (Respiratory Failure) 07/2008

Drug/Important Bio-Agent (IBA)

4	Analgesics (Analgesic Drugs)IBA 04/2021 - 07/2008
4	Opioid Analgesics (Opioids)IBA 09/2014 - 07/2008
2	A 967079IBA 01/2020 - 01/2019
2	Fentanyl (Sublimaze)FDA LinkGeneric 09/2014 - 07/2008
1	AcidsIBA 01/2020
1	Amiloride (Midamor)FDA LinkGeneric 01/2020
1	OximesIBA 01/2019
1	AnkyrinsIBA 01/2019
1	JT010IBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Medical MarijuanaIBA 10/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2016
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2016
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2016
1	Tapentadol FDA Link 01/2011
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2011
1	Buprenorphine (Subutex)FDA LinkGeneric 07/2008
1	Central Nervous System Depressants (CNS Depressants)IBA 07/2008
1	Hydromorphone (Dilaudid)FDA LinkGeneric 07/2008
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2008
1	Methadone (Dolophine)FDA LinkGeneric 07/2008
1	Morphine (MS Contin)FDA LinkGeneric 07/2008
1	Oxycodone (Oxycontin)FDA LinkGeneric 07/2008

Therapy/Procedure

4	Pain Management 01/2015 - 01/2011
3	Therapeutics 01/2015 - 09/2003
3	Drug Therapy (Chemotherapy) 09/2014 - 09/2003
2	Injections 01/2020 - 01/2019
2	Analgesia 09/2014 - 01/2011
1	Denervation 04/2021
1	Immunotherapy 07/2008
1	Transcutaneous Electric Nerve Stimulation (TENS) 09/2003